PTSM: Pharmaceutical Technology Sourcing and Management, Jul 12, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Jul 12, 2011
APIs
SOCMA Focuses on Concerns of Batch and Custom Manufacturers
By Patricia Van Arnum
SOCMA President and CEO Lawrence D. Sloan discusses the key policy initiatives and activities of the association.
Tracking Pharmaceutical and API Growth in China
By Patricia Van Arnum
Strong growth is projected for the pharmaceutical industry in China, offering opportunities for drug companies and manufacturers of active pharmaceutical ingredients.
Outsourcing
Wanted: Better Upstream Bioprocessing Technologies
By Eric Langer
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Pharma Partner Focus
Almac Expands in North America
By Patricia Van Arnum
With a new North American headquarters and expanded operations, Almac is furthering its transatlantic approach to contract development and manufacturing.
CSR and Sustainability Forum
Pharma Industry Prepares for UN High-Level Meeting on Noncommunicable Diseases
The International Federation of Pharmaceutical Manufacturers and Associations issues a Framework for Action for noncommunicable diseases.
Sustainability at Work: Solar Energy
By Erik Greb
New Age Industries, a manufacturer of plastic molding and fittings for the pharmaceutical and biopharmaceutical industries, implements a solar-energy project at its Pennsylvania facility.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Click here